Eligibility and Compliance

1. Eligibility

Geographic Location:

Open to researchers globally. There are no restrictions based on geographic location, and international applicants are encouraged to apply.

Entity Type:

Eligible entities include academic/research institutions, universities, biotechnology companies, and other organizations engaged in life sciences research.

Any local, state, provincial, or other government or government agency, and officials or employees thereof, are not eligible to participate.

Healthcare organizations, including hospitals, healthcare professionals, and employees thereof, are not eligible.

Legal Status:

Must be legally recognized and authorized to conduct research in their respective jurisdictions.

Affiliation Restrictions:

Employees of GenScript or its affiliates, as well as their immediate family members and household members, are ineligible to apply.

Collaborations:

Each eligible entity may submit only one (1) application representing the sole efforts of that entity. Collaborations among two (2) or more entities will not be considered unless Genscript provides explicit written consent.

Compliance:

Applicants must comply with all applicable, state, and local laws and regulations.

Void Where Prohibited:

The program is open to participants worldwide, except where prohibited by law.

Participation constitutes the applicant's full and unconditional agreement to the program's rules and decisions, which are final and binding in all matters related to the grant.

GenScript reserves the right to verify the eligibility of applicants and to disqualify any application that does not meet the specified criteria. The eligibility criteria aim to ensure a fair and open application process for researchers across diverse backgrounds and geographic locations.

2. Confidentiality and Conflicts of Interest:

Confidentiality Terms:

GenScript recognizes the sensitive nature of research proposals and respects the proprietary information submitted by applicants. Therefore, all details provided in the grant applications, including methodologies, data, and preliminary findings, will be treated as confidential.

Notice on Conflicts of Interest:

To ensure an unbiased and fair evaluation process, applicants are required to disclose any potential conflicts of interest that may compromise the impartiality of the review. Conflicts of interest may include, but are not limited to, financial relationships with GenScript, familial or professional relationships with members of the review committee, or any other affiliations that could influence the evaluation process. In the event of a conflict, GenScript reserves the right to take appropriate measures, including the disqualification of a proposal or the recusal of conflicted individuals from the evaluation process. GenScript is committed to upholding the highest standards of transparency, fairness, and confidentiality throughout the application and evaluation process for the GenScript Life Science Research Grant Program.

3. Rights and Consent for Use of Participant Information and Project Data:

To finalize award distribution, GenScript’s Life Science Research Grant team will present a “Collaboration Agreement” for review to the grant recipients. The agreement aims to ensure that GenScript is publicly recognized in diverse forums for its contribution through the grant program. GenScript will not request that applicants share intellectual property (IP) rights to their research, findings, or products through this agreement. The awardee would own all rights in performing Services under the LSR Grant Program.

As a condition of participation, and in consideration for the opportunity to apply for the GenScript Life Science Research Grant Program, applicants agree to grant GenScript and its affiliates, and subsidiaries an irrevocable, perpetual, non-exclusive, and royalty-free right to use the participant's name, image, and likeness for any purpose and in all media, whether now known or hereinafter created, throughout the world without the expectation of compensation. Additionally, participants provide consent for GenScript and its affiliates to publish news releases regarding the GenScript Life Science Research Grant Program, grant recipients, and awarded research project titles on their websites and/or social media pages for promotional marketing purposes indefinitely. Participants further consent to being contacted by GenScript or its representatives for follow-up marketing activities related to the program. GenScript ultimately reserves the right to use any data generated from awarded research projects in marketing activities. However, GenScript will work with award recipients to determine the timing and content of such marketing activities.

GenScript reserves the right to make the final determination of funding for the Life Science Research Grant (LSRG) Program. The selection of individuals to receive LSRG awards, the total number of awards, and the amount of funding provided are solely determined by GenScript. Applicants may request a specific budget based on the proposal submitted during the application process; however, GenScript retains all rights to decide on the funding level and the extent of support provided to each awardee toward services and reagents.